Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May;10(5):303-304.
doi: 10.1016/S2213-8587(22)00075-4. Epub 2022 Apr 1.

Dapagliflozin in young people with type 2 diabetes

Kalie L Tommerdahl  1 , Robert G Nelson  2 , Petter Bjornstad  3
Affiliations
Comment

Dapagliflozin in young people with type 2 diabetes

Kalie L Tommerdahl et al. Lancet Diabetes Endocrinol. 2022 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

PB reports serving as a consultant for AstraZeneca, Bayer, Bristol-Myers Squibb, Boehringer Ingelheim, Eli-Lilly, LG Chemistry, Sanofi, Novo Nordisk, and Horizon Pharma. PB also serves on the advisory boards of AstraZeneca, Bayer, Boehringer Ingelheim, Novo Nordisk, and XORTX. KLT and RGN declare no competing interests. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the US National Institutes of Health.

Comment on

References

    1. Tamborlane W EFFICACY AND SAFETY OF DAPAGLIFLOZIN IN CHILDREN AND YOUNG ADULTS WITH TYPE 2 DIABETES: A PROSPECTIVE, MULTICENTRE, RANDOMIZED, PARALLEL GROUP PHASE 3 STUDY. Lancet Diabetes Endocrinol (2022). - PMC - PubMed
    1. Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, Imperatore G, Linder B, Marcovina S, Pettitt DJ, Pihoker C, Saydah S, Wagenknecht L & Study S. f. D. i. Y. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012. N Engl J Med 376, 1419–1429, doi:10.1056/NEJMoa1610187 (2017). - DOI - PMC - PubMed
    1. TÖNnies T, Saydah S, Isom S, Dabelea D, Divers J, Mayer-Davis EJ, Pihoker C, Dolan LM, Brinks R, Dagostino R, Hoyer A & Imperatore G 156-OR: Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years through 2060. Diabetes 70, doi:10.2337/db21-156-OR (2021). - DOI - PMC - PubMed
    1. Consortium R & Investigators RC Effects of Treatment of Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes With Metformin Alone or in Combination With Insulin Glargine on beta-Cell Function: Comparison of Responses In Youth And Adults. Diabetes, doi:10.2337/db19-0299 (2019). - DOI - PMC - PubMed
    1. Group TS, Bjornstad P, Drews KL, Caprio S, Gubitosi-Klug R, Nathan DM, Tesfaldet B, Tryggestad J, White NH & Zeitler P Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med 385, 416–426, doi:10.1056/NEJMoa2100165 (2021). - DOI - PMC - PubMed

Publication types

MeSH terms